Latest News:28/June/2013:MESH Sceintefic program started today..»28/June/2013:بدء نشاط مدرسة الشرق الأوسط لأمراض الكبد..»13/May/2013:adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma..»13/May/2013:Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening..»13/May/2013:FDA Limits Duration, Usage of Tolvaptan Due to Possible Liver Injury..»13/May/2013:Nephrology Online Course (NOC) on CKD..»4/May/2013:FDA OKs Kcentra for Fast Fix of Coumadin Bleeds..»22/April/2013:فى ذمه الله..وفاه حرم أ.د. عمرو حلمى..»17/April/2013:سيد الرئيس " محمد مرسي  يكرم أ/د جمال الدين عصمت في عيد العلم بمناسبة حصول سيادته على جائزة الدولة التقديرية في العلوم الطبية لعام..»27/December/2011:إختيار الأستاذ الدكتور/ جمال عصمت نائبا لرئيس جامعة القاهرة للدراسات العليا..»16/November/2011:Dr.Zayady had passed away..»16/November/2011:البقاء لله :توفى اليوم الى رحمة الله د. عبد الرحمن الزيادى أستاذ الكبد والجهازهضمى..»13/October/2011:دعوة للإنضمام إلى الطريق الأخر...القوة الثالثة..»26/August/2011:توفى الى رحمة الله تعالى بألمانيا المغفور له بإذن الله - الاستاذ الدكتور/ مصطفى كمال..»29/May/2011:New Treatments for Hepatitis C..»23/March/2010:Nitazoxanide is now available in Egypt..»23/March/2010:When and how to evaluate mildly elevated liver enzymes in apparently healthy patients..»28/February/2010:نقابة الأطباء تفتح باب التبرعات لتقديم الزكاة لأعضائها..»15/January/2010:New Project By NMMA supported by Coca Cola International..»

Member's Login

login:
Password:
Skip Navigation Links.

Egyptian Liver Journal>>April issue

Books Library:

Migrating Birds:



Suggestion Home

Latest News


?Here you can read about the latest news from the network that we found usful for every client intersted in our site's topics,here u will find a variety of news that we hope it afficts your life positively..!!


Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening- 5/13/2013 12:00:00 AM

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening Full Text BMC Infectious Diseases, 04/19/2013  Evidence Based Medicine  Clinical Article Hahne SJM et al. – To inform screening policies the authors assessed (1) the hepatitis B surface antigen (HBsAg) and anti–hepatitis C virus antibodies (anti–HCV–Ab) prevalence for 34 European countries; and (2) the cost–effectiveness of screening for chronic HBV and HCV infection. The prevalence of chronic HBV and HCV infection varies widely between European countries. Anti–HCV–Ab screening of PWID and HBsAg screening of pregnant women and migrants are European public health priorities. Cost–effectiveness analyses may need to take effect of antiviral treatment on preventing HBV and HCV transmission into account. Methods The authors searched peer-reviewed literature for data on HBsAg and anti-HCV-Ab prevalence and cost-effectiveness of screening of the general population and five subgroups, and used data for people who inject drugs (PWID) and blood donors from two European organizations. Of 1759 and 468 papers found in the prevalence and cost-effectiveness searches respectively, the authors included 124 and 29 papers after assessing their quality. The authors used decision rules to calculate weighted prevalence estimates by country. Results The HBsAg and anti-HCV-Ab prevalence in the general population ranged from 0.1%-5.6% and 0.4%-5.2% respectively, by country. For PWID, men who have sex with men and migrants, the prevalence of HBsAg and anti-HCV-Ab was higher than the prevalence in the general population in all but 3 countries. There is evidence that HCV screening of PWID and HBsAg screening of pregnant women and migrants is cost-effective.

Search News


Date From:
To:
 



Upcoming Events

International Events:


National Events:

Pioneers: